LOUISVILLE, Ky. / Oct 13, 2023 / Business Wire / For the third consecutive year, the Centers for Medicare and Medicaid Services (CMS) has awarded the highest possible quality rating to leading health and well-being company Humana Inc. (NYSE: HUM) for its northern Kentucky HMO plan offered in Boone, Campbell, Grant, Kenton and Pendleton counties. The Humana Health Plan of Ohio, Inc. HMO plan is one of four Humana contracts that received a 5-star rating for 2024 on CMS’s 5-star rating system.
Another one of Humana’s four top-rated contracts received the 5-star rating for the first time, adding a new Kentucky county to the list; the Humana Medical Plan Inc. HMO plan is offered in Jefferson County. Combined, the four 5-star contracts cover approximately 790,000 Humana members nationwide, more than double the number of members in 5-star plans in 2023.
“We are thrilled to report this repeat achievement and so proud of the Kentucky team that works so hard to deliver the highest-rated member experience,” said Humana’s Medicare President for Kentucky Eric Bohannon. “This top rating reflects our close clinical collaboration with our value-based providers and the quality health care they bring to our Kentucky members.”
Vice President of Managed Care for St. Elizabeth Healthcare in northern Kentucky Bill Banks said, “We’re proud to partner with Humana to deliver high quality care to its members. The Humana team shares our mission of focusing on value-based care that delivers the best results for our patients.”
Kentucky Medicare Advantage member Nancy R. says she values Humana’s whole-person approach to caring for its members.
“I appreciate how Humana really wants us to be the healthiest version of ourselves and provides us with resources to accomplish that,” Nancy said.
About Medicare Advantage Enrollment
The Medicare Advantage and Prescription Drug Plan Annual Election Period (AEP) begins Oct. 15 and continues through Dec. 7. During this enrollment period, people eligible for Medicare can choose Medicare Advantage and Prescription Drug Plans for the upcoming year – with coverage that takes effect Jan. 1.
People eligible for Medicare may make a one-time election to enroll in a plan offered by an MA organization with a Star Rating of 5 stars during the year in which that plan has the 5-star overall performance rating, provided the enrollee meets the other requirements to enroll in that plan. This 5-star special election is available Dec. 8 through Nov. 30 of the following year.
For more information about Humana’s 2024 Medicare offerings, visit Humana.com/Medicare or call toll-free 1-800-706-1368 (TTY: 711). Licensed sales agents are available 8 a.m. to 8 p.m. local time, seven days a week.
About CMS Star Ratings
The CMS rating system measures the excellence of Medicare plans nationally each year. A plan may receive a rating between one and five stars, with five stars representing the highest rating. CMS uses information from member-satisfaction surveys, health plans, and health care providers to assign overall Star Ratings to plans. The rating system uses more than 40 different quality measures across nine categories, including:
Additional information about the CMS Star Ratings can be found at: www.medicare.gov.
About Humana
Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.
Additional Information
Humana is a Medicare Advantage HMO organization with a Medicare contract. Enrollment in any Humana plan depends on contract renewal. Every year, Medicare evaluates plans based on a 5-star rating system. Other providers are available in the Humana network.
Last Trade: | US$357.86 |
Daily Change: | -7.28 -1.99 |
Daily Volume: | 920,436 |
Market Cap: | US$43.090B |
August 19, 2024 August 08, 2024 July 31, 2024 July 25, 2024 |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREChimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB